Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates.

Leiomyosarcoma (LMS) is a malignant soft tissue sarcoma (STS) with a dismal prognosis following metastatic disease. Chemotherapeutic intervention has demonstrated to have modest clinical efficacy with no curative potential in LMS patients. Previously, we demonstrated pan-HDAC inhibition to have a su...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS ONE
Main Authors: Gonzalo Lopez, Danielle Braggio, Abeba Zewdu, Lucia Casadei, Kara Batte, Hemant Kumar Bid, David Koller, Peter Yu, Obiajulu Hans Iwenofu, Anne Strohecker, Edwin Choy, Dina Lev, Raphael Pollock
Formato: Artigo
Publicado em: Public Library of Science (PLoS) 2017-01-01
Acesso em linha:http://europepmc.org/articles/PMC5706733?pdf=render
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

http://europepmc.org/articles/PMC5706733?pdf=render

Registos relacionados